RAPIVAB
RAPIVAB
Approved
DIN Number
02460319
Drug Class
Human
Market Date
N/A
Company
HC
BioCryst制药
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02460319
AIG Number0158751001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AH NEURAMINIDASE INHIBITORS
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification08:18.28
Health Canada Classification
ACTIVE INGREDIENTS (1)
PERAMIVIRActive
Strength: 10 MG / ML
Monograph: PERAMIVIR